TITLE

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

AUTHOR(S)
Harrison, S. A.; Oliver, D.; Arnold, H. L.; Gogia, S.; Neuschwander-Tetri, B. A.
PUB. DATE
October 2008
SOURCE
Gut;Oct2008, Vol. 57 Issue 10, p1441
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Clinical predictors of advanced non-alcoholic liver disease (NAFLD) are needed to guide diagnostic evaluation and treatment. Methods: To better understand the demographics of NAFLD and risk factors for advanced disease, this study analysed 827 patients with NAFLD at two geographically separate tertiary medical centres. Results: The cohort was 51% female and had a median body mass index (BMI) of 33 kg/m2 3% had a normal BMI. Common co-morbidities included hypertension (60%) and diabetes (35%); insulin resistance was present in 91% and advanced fibrosis in 24% of patients. When comparing patients with no fibrosis or mild fibrosis to those with advanced fibrosis, BMI ⩾ 28 kg/m2, age >50 years, and aspartate transarninase/alanine amino-transferase (AST/ALT) ratio ⩾0.8, a quantitative assessment check index (QUICKI) score <0.294 (equivalent to horneostatasis model assessment (HOMA) >6.2) and the presence of diabetes mellitus (OM) were individually associated by univariate analysis with odds ratios (ORs) of ⩾2.4 for advanced fibrosis. Based on the results of forced entry logistic regression analysis, three variables were combined in a weighted sum (BMI ⩾28 = 1 point, AAR of ⩾0.8 = 2 points, DM = 1 point) to form an easily calculated composite score for predicting advanced fibrosis called the BARD score. A score of 2-4 was associated with an OR for advanced fibrosis of 17 (confidence interval 9.2 to 31.9) and a negative predictive value of 96%. Conclusions: Insulin resistance and its co-morbidities are often present in patients with NAFLD. An easily calculated score based on readily available clinical data can reliably exclude the presence of advanced fibrosis in these patients, particularly among non-diabetics.
ACCESSION #
34640829

 

Related Articles

  • CASE FATALITY AND MORBIDITY IN PATIENTS WITH ALCOHOLIC LIVER DISEASE.  // Gut;Apr2004 Supplement 3, Vol. 53, pA88 

    Alcoholic liver disease (ALD) is a heterogenous condition, in terms of its presentation, clinical course, and mortality. Available data on mortality at the national level show a rising trend in Great Britain in the face of a steady fall in many other European countries. A study was carried out...

  • LIVER IRON GRADE IN DECOMPENSATED ALCOHOLIC LIVER DISEASE: PROGNOSTIC SIGNIFICANCE AND RELATION TO HFE GENOTYPE.  // Gut;Apr2004 Supplement 3, Vol. 53, pA88 

    Moderate liver iron accumulation is common in alcoholic liver disease (ALD). Its causation is poorly understood but it has been associated with a poor outlook. 0, 1, 2, 3, and 4 iron was found in 41, 20, 12, 5, and 0 of the 78 patients respectively. Iron was seen in hepatocytes in 34 patients,...

  • Pathogenesis and novel therapeutic targets of alcoholic liver disease. CHANG Binxia; WANG Hua; ZHOU Zhengsheng // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;2014, Vol. 30 Issue 2, p113 

    Alcoholic liver disease (ALD) is a leading cause of chronic liver disease worldwide; however, the pathogenesis of ALD is not fully understood and there are no targeted therapies for ALD. In this review article, we summarize the findings from recent studies that have characterized the...

  • Keratin 8 variants are infrequent in patients with alcohol-related liver cirrhosis and do not associate with development of hepatocellular carcinoma. Usachov, Valentyn; Nahon, Pierre; Lunova, Mariia; Ziol, Marianne; Rufat, Pierre; Sutton, Angela; Beaugrand, Michel; Strnad, Pavel // BMC Gastroenterology;2012, Vol. 12 Issue 1, p147 

    Background: Keratins 8/18 (K8/K18) are established hepatoprotective proteins and K8/K18 variants predispose to development and adverse outcome of multiple liver disorders. The importance of K8/K18 in alcoholic liver disease as well as in established cirrhosis remains unknown. Methods: We...

  • THE GLASGOW ALCOHOLIC HEPATITIS SCORE IDENTIFIES PATIENTS LIKELY TO BENEFIT FROM CORTICOSTEROIDS. Forrest, E. H.; Morris, J. M.; Stewart, S.; Day, C. P. // Gut;Apr2004 Supplement 3, Vol. 53, pA13 

    The use of corticosteroids in the treatment acute alcoholic hepatitis remains controversial. Their use has been recommended for patients with a discriminant function. The recently described Glasgow Alcoholic Hepatitis Score (GAHS) appears to have a greater accuracy in predicting patient outcome....

  • LIVER DISEASES.  // Alcohol & Alcoholism;2015 Supplement, Vol. 50, pi47 

    The article presents a study conducted by T. Haseba and colleagues which evaluate the development of alcoholism and how alcohol dehydrogenase (ADH1) was regulated.

  • Expression of the β1 Chain (CD29) of Integrins and CD45 in Alcoholic Liver Disease. Chedid, Antonio; Mendenhall, Charles L.; E. Moritz, Thomas; French, Samuel W.; Chen, Thomas S.; Morgan, Timothy R. // American Journal of Gastroenterology;Nov1993, Vol. 88 Issue 11, p1920 

    Objectives: In the active stages of alcoholic liver disease (ALD), we have shown previously an enhanced expression of either CD4 or CD8 molecules on CD3+T cells. Class I and II MHC molecules expression were enhanced on lymphocytes, and on the cell membrane of hepatocytes, thus suggesting that an...

  • Intragastric Ethanol Infusion Model for Cellular and Molecular Studies of Alcoholic Liver Disease. French, Samuel W. // Journal of Biomedical Science;2001, Vol. 8 Issue 1, p20 

    The intragastric alcohol infusion rat model (IAIRM) of alcoholic liver disease (ALD) has been utilized in various laboratories to study various aspects of ALD pathogenesis including oxidative stress, cytokine upregulation, hypoxic damage, apoptosis, ubiquitin-proteasome pathway and CYP2E1...

  • PATHOGENESIS OF ALCOHOLIC HEPATITIS. Albot, Guy; Herman, Jean; Faye, Claude M.; Chardard, Suzanne // American Journal of Gastroenterology;Jan1957, Vol. 27 Issue 1, p53 

    Focuses on the pathogenesis of alcoholic hepatitis. Results of investigation into cirrhosis of hepatic origin; Information on chemical studies to evaluate liver function; Histobiological syndromes of alcoholic hepatitis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics